Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: A national database study of 24 059 melanoma cases

JAMA Dermatology

Volumn 151, Issue 10, 2015, Pages 1087-1095

  Helvind, Neel Maria ^a   Hölmich, Lisbet Rosenkrantz ^b   Smith, Sigrun ^c   Glud, Martin ^d   Andersen, Klaus Kaae ^c   Dalton, Susanne Oksbjerg ^c   Drzewiecki, Krzysztof Tadeusz ^a,b  

^a University of Copenhagen   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRESLOW THICKNESS; CANCER INCIDENCE; CANCER MORTALITY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; ICD-10; IN SITU MELANOMA; INVASIVE MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; ONCOLOGICAL PARAMETERS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY PREVENTION; ULCER; AGE DISTRIBUTION; CARCINOMA IN SITU; FACTUAL DATABASE; INCIDENCE; MELANOMA; MIDDLE AGED; PATHOLOGY; SEX RATIO; SKIN NEOPLASMS; TUMOR INVASION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CARCINOMA IN SITU; DATABASES, FACTUAL; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; SEX DISTRIBUTION; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84944345895     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.1481     Document Type: Article

References (24)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0: Cancer Incidence and Mortality World wide: IARC Cancer Base No. 11. http://globocan. iarc.fr. Accessed July 28, 2014.
2. Pruthi DK, Guilfoyle R, Nugent Z, Wiseman MC, Demers AA. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005. J AmAcad Dermatol. 2009;61(1):44-50.
3. Whiteman DC, Bray CA, Siskind V, Green AC, Hole DJ, Mackie RM. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur J Cancer Prev. 2008;17(3):243-250.
4. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England: incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95(1):91-95.
5. Marcos-Gragera R, Vilar-Coromina N, Galceran J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24(9):1083-1088.
6. Chellini E, Crocetti E, Carli P, Martini A, Giovannetti L. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy. Melanoma Res. 2007;17(2):129-130.
7. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674.
8. Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 6.1 (25.04. 2014). http://www.ancr.nu. Accessed July 20, 2014.
9. Erickson C, Driscoll MS. Melanoma epidemic: facts and controversies. Clin Dermatol. 2010;28(3):281-286.
10. Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E. Trends of cutaneous melanoma in the Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol. 2012;23(2):524-530.
11. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
12. Danish Melanoma Group. Dansk Melanom Database. National Årsrapport 2013. https://www.sundhed.dk/sundhedsfaglig/kvalitet/kliniske-kvalitetsdatabaser/kraeft/dansk-melanom-database/. Accessed December 14, 2014.
13. Bay C, Kejs AM, Storm HH, Engholm G. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish population-based register study 1989-2011. Cancer Epidemiol. 2015;39(1):1-7.
14. Schneider JS, Moore DH II, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J AmAcad Dermatol. 2008;58(5):741-749.
15. Nørgaard C, Glud M, Gniadecki R. Are all melanomas dangerous? Acta Derm Venereol. 2011;91(5):499-503.
16. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345-1389.
17. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ. 2005;331(7515):481. doi:10.1136/bmj.38516.649537.E0.
18. Nachbar F, Stolz W, Merkle T, et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30(4):551-559.
19. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341-1348.
20. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer. 1997;73(2):198-203.
21. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(suppl 61):1-6.
22. Danish Cancer Society. Solundersøgelsen 2010. 2010:1-59. http://www.cancer.dk/dyn/resources/File/file/8/3898/1404919835/samlet-solundersoegelse-2010-final-17052011-m-forsidedf.pdf. Accessed December 14, 2014.
23. Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control. 1991;2(6):401-411.
24. Lyth J, Hansson J, Ingvar C, et al; Swedish Melanoma Study Group. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register. Br J Dermatol. 2013;168(4):779-786.